Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
about
P1343
Therapies targeting cancer stem cells: Current trends and future challengesCXCR4 in breast cancer: oncogenic role and therapeutic targetingImportant Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic ChallengeSelection of metastatic breast cancer cells based on adaptability of their metabolic stateTargeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.In vivo lymphatic imaging of a human inflammatory breast cancer model.Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells.The emerging role of CXC chemokines and their receptors in cancer.Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents.Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).Imaging agents for the chemokine receptor 4 (CXCR4).Cancer stem cells, microRNAs, and therapeutic strategies including natural products.A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence.
P2860
Q26777880-CFF4332F-A0D8-47B2-A1C9-73A8DEFA8EE3Q26781915-96E56290-2DDA-416A-852C-A6EE42C1FD3FQ28552551-A981F758-7ED3-4710-9B83-D9940309884BQ28730146-5345016F-64BA-4762-AE89-2A6998ABFB05Q30500481-D48C2D86-F124-42D8-B56A-87699465EB94Q30596741-8CA6DA10-3487-4387-B52C-D5F138DABD5DQ30836426-FFE00140-B3F7-4CDF-9050-137AA2B0EFC2Q34166339-AB61C4E9-A4C4-46E5-81B3-D818FA788C9BQ34263645-BC5457B7-F230-4182-A89A-A77A1144D4DEQ34287510-8C601A15-7027-42C1-910B-78A095469A46Q35036663-58914DA4-7C34-4B0B-A866-D2A4B680574EQ36243278-33B97CCE-43C7-4606-9A89-083CFD1E59A5Q37685449-37F8B070-3452-4EDC-B385-F77A3A6B3CFBQ37689609-9267DCE1-3CBA-4026-8F50-0FE784B89CB7Q37964960-4CB1F542-15B7-424B-9BFB-0C4CB9CDC3CEQ38003847-D0DFEADA-399A-4E84-83DE-CE3F9216D5EAQ38022430-5F713417-811C-4333-86EF-91FE3E65BC5CQ38023238-8372214B-6E48-4534-933C-113B71146FEFQ39514915-802F2BC0-2DB5-46A5-9D93-35DE284C8F2DQ40109819-8929DC73-DE8A-4B9D-891D-C9F3DA2D7865Q47850217-37888D2A-A62B-4349-AB43-FC02E97BA1A1Q53701934-E9B3509E-F22D-4CB7-9637-2FEE5EFCBA58
P2860
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@en
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@nl
type
label
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@en
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@nl
prefLabel
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@en
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@nl
P2093
P921
P1476
Evaluation of a CXCR4 antagoni ...... of inflammatory breast cancer.
@en
P2093
Anthony Lucci
Balraj Singh
Cecilia Martin
Eugene H Huang
Kailash Mosalpuria
Kendra R Cook
Massimo Cristofanilli
Savitri Krishnamurthy
P2888
P304
P356
10.1007/S10585-010-9321-4
P4510
P577
2010-03-13T00:00:00Z